Preclinical have studies proposed the involvement of the PDT-induced release of DAMPs and CD8+T cell activation during the abscopal response, which subsequently stimulates the immune system on a broader level to kill treated and untreated tumor masses, thereby contributing to the long-term prevention of cancer recurrence. The gene discussed is CD8A; the disease is cancer.